Evaluation of the effect of metabolic therapy on the state of blood vessels in estrogen deficiency and hypertension

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The article presents the results of duplex scanning of the common carotid arteries (CCA) and assessment of the structural and functional state of the vascular bed women with arterial hypertension (AH) with hypoestrogenemia. It was found that in patients with hypertension with a reduced level of estradiol, there is an expansion of the lumen of the CCA, a decrease in the speed of blood flow in the carotid arteries of a rectilinear course, without hemodynamically significant stenoses, which indicates structural and functional changes in the vascular wall. In the studied patients, in almost every third case, an inertial type of vasomotor reaction is detected before treatment, which indicates the contribution of dishormonosis to the progression of hypertension due to an increase in the stiffness of the vascular wall and the development of endothelial dysfunction. Combination therapy with BioDihydroquercetin and ACE inhibitor improves the structural and functional characteristics of the vascular wall of the CCA, has a positive effect on endothelial dysfunction, reduces the stiffness of the vascular wall of the arteries compared with patients taking ACE inhibitor monotherapy. The drug BioDihydroquercetin, produced with trade mark “Baikal Legend”, is a natural antioxidant, capillaroprotector, strengthens blood vessels, improves blood microcirculation, and is recommended to slow down the aging process of the body.

Full Text

Restricted Access

About the authors

M. M. Khabibulina

Ural State Medical University

Author for correspondence.
Email: m.xabibulina@mail.ru

Candidate of Medical Sciences

Russian Federation, Yekaterinburg

M. D. Shamilov

Ural State Medical University

Email: m.xabibulina@mail.ru
Russian Federation, Yekaterinburg

References

  1. Moiseev V.S., Kobalava ZH.D. Arterial hypertension in older age groups. Monograph, 2002; 448 (in Russ.).
  2. Oganov R.G. Prevention of cardiovascular diseases: the possibilities of practical health care. Cardiovascular therapy and prevention. 2002; 1: 5–9 (in Russ.).
  3. Habibulina M.M. Cardiovascular risk in premenopausal estrogen deficiency. Yekaterinburg, 2014 (in Russ.).
  4. Batalova A.A., KhovaevaYa.B., Berg M.D. Stages of endothelial dysfunction in the development of hypertension and atherosclerosis. Cardiovascular Therapy and Prevention. 2008; 7 (6): 44 (in Russ.).
  5. Ryabikov A.N., Malyutina S.K., Ivanov S.V. Arterial wall stiffness and pulse wave reflection: an association with established and debated determinants of cardiovascular disease. Proceedings of the Congress of «Chelovek i Lekarstvo». 2007; р. 11–4 (in Russ.).
  6. KhovaevaYa.B., Syromyatnikova T.N., Golovskoy B.V. The state of the intima-median complex of arteries of different types depending on the level of arterial pressure. Materials of the XI All-Russian Scientific and Educational Forum «Cardiology». 2009; р. 30–304 (in Russ.).
  7. Khabibulina M.M. Left ventricular structure and geometry, peripheral artery endotheliumdependent vasodilatation, antihypertensive effect of ACE inhibitors, and hormone replacement therapy in premenopausal women with arterial hypertension. Cardiovascular Therapy and Prevention. 2011; 10 (2): 24–8 (in Russ.). doi: 10.15829/1728-8800-2011-2-24-28
  8. Nelidova A.V., Bunova S.S., Ostapenko V.A. Diagnostic features of early detection of endothelial dysfunction in patients with hypertension. Mat. Ros. national congr. cardiologists. Cardiovascular therapy and prevention. 2008; 7 (6): 262–3 (in Russ.).
  9. Khabibulina M.M. Comparison of structural and geometric changes of the left heart, systolic and diastolic functions in women with hypertension in late fertile period and menopause. Kardiologiya i serdechno-sosudistaya khirurgiya. 2009; 2 (2): 75–8 (in Russ.).
  10. Osipova E.V., Mel'nikova L.V., Bartosh L.F. Elastic properties of the wall of the common carotid arteries in arterial hypertension depending on the group of cardiovascular risk. Mat. Ros. national congr. cardiologists. Cardiovascular therapy and prevention. 2008; 7 (6): 273–4 (in Russ.).
  11. Protasov K.V., Sinkevich D.A., Dzizinskij A.A. Evaluation of the relationship between the parameters of the morphofunctional state of the common carotid artery in various types of arterial hypertension. Mat. Ros. national congr. cardiologists. Cardiovascular therapy and prevention. 2008; 7 (6): 303 (in Russ.).
  12. Ivanova O.V., Balahonova T.V., Soboleva G.N. The state of endothelium-dependent vasodilatation of the brachial artery in hypertensive patients, assessed using high-pressure ultrasound. Cardiology. 1997; 7: 41–6 (in Russ.).
  13. Khabibulina M. The vascular bed in estrogen deficiency with hypertension and obesity. Vrach. 2018; 29 (2): 65–8 (in Russ.). doi: 10.29296/25877305-2018-02-16
  14. Kozlova M.V. Features of microcirculation disorders in postmenopausal women with arterial hypertension. Diss. … kand. med. nauk. Ivanovo, 2008 (in Russ.).
  15. Khabibulina M.M. Structural and functional parameters of the vascular bed in premenopausal hypertensive women. Ter arkh. 2011; 83 (12): 11–5 (in Russ.).
  16. Makolkin V.I., Podzolkov V.I., Pavlov V.I. The state of microcirculation in hypertension. Cardiology. 2002; 7: 36–40 (in Russ.).
  17. Khabibulina M.M. The vascular bed in premenopausal women with arterial hypertension and dyslipidemia in estrogen deficiency. Vrach. 2013; 12: 31–6 (in Russ.).
  18. Mendelsone M.E., Karas R. The protective effects of estrogen on cardiovascular system. N Engl J Med. 1999; 340: 1801–1. doi: 10.1056/NEJM199906103402306
  19. Kudryashova O.Yu., Zateyshchikov D.A., Sidorenko B.A. A possible role of estrogens in the prevention and treatment of atherosclerosis in postmenopausal women. Cardiology. 1998; 4: 51–8 (in Russ.).
  20. Dyadyk A.I., Bagriy A.E., Yarovaya N.F. et al. Effect of angiotensin-converting enzyme inhibitors on left ventricular hypertrophy in patients with arterial hypertension. Ter arkh. 1995; 8: 65–7 (in Russ.).
  21. Khabibulina M.M. Therapy in women with hypertension and estrogen deficiency in the late fertile period. Vrach. 2016; 4: 45–9 (in Russ.).
  22. Karpov Yu.A. ACE inhibitors: from lowering blood pressure to preventing complications and improving prognosis. Serdtse. 2002; 4: 192–4 (in Russ.).
  23. Khabibulina M.M. Hypotensive effect of diroton and its influence on the structural and geometrical parameters of the left heart chambers in premenopausal women with hypertension. Vrach. 2008; 9: 59–62 (in Russ.).
  24. Kislyak O.A. ACE inhibitor lisinopril in the treatment of elderly patients with systolic-diastolic hypertension. Lechebnoe delo. 2007; 2: 2–7 (in Russ.).
  25. Khabibulina M.M. Changes in structural and geometric parameters, hypotensive efficacy of the angiotensin-converting enzyme inhibitor lisinopril in women with hypertension in the premenopausal period, depending on the level of female sex hormones. Ural Medical Journal. 2008; 9 (49): 74–8 (in Russ.).
  26. Postnikova S.L. ACE inhibitors in cardiological practice. RMJ. 2004; 12 (7): 496–500 (in Russ.).
  27. Tatarenko O.K., Nosenko E.M., Alekhin M.N. The effect of the angiotensin-converting enzyme inhibitor moexipril on central and peripheral hemodynamics in menopausal women with moderate hypertension. Cardiology. 1999; 39 (1): 48–53 (in Russ.).
  28. Khabibulina M.M. Evaluation of influence of long-term therapy with angiotensin converting enzyme inhibitor lisinopril on morphofunctional parameters of the left ventricl peripheral artery endothelium disfunction, and painless myocardial ischemia in premenopausal women with hypertension. Cardiology. 2010; 50 (1): 16–21 (in Russ.).
  29. Glezer M.G. Gender differences in effectiveness and safety of Diroton (lizinopril) treatment of arterial hypertension under diurnal monitoring control of blood pressure. Problems of women health. 2007; 2 (1): 1–8 (in Russ.).
  30. Khabibulina M.M. Effect of angiotensin converting enzyme lisinopril on the state of vascular bed in premenopausal women with arterial hypertension. Cardiology. 2013; 53 (2): 38–42 (in Russ.).
  31. Lusher T.F., Barton М. Endothelins and endothelin receptor antagonists. Theraupetic concentrations for novel class of cardiovascular drugs. Circulation. 2000; 102: 2324–32. doi: 10.1161/01.cir.102.19.2434
  32. Panza J.A., Quyyumi A.A., Brush J.E. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. Engl J Med. 1990; 323: 22–27. doi: 10.1056/NEJM199007053230105
  33. Vlasov T.D., Petrischev N.N., Lazovskaya O.A. Endothelial dysfunction. Do we understand this term properly? Messenger of Anesthesiology and Resuscitation. 2020; 17 (2): 76–84 (in Russ.). doi: 10.21292/2078-5658-2020-17-2-76-84
  34. Usolceva O.N. Prevention of accelerated aging and «diseases of civilization» with the help of natural geroprotectors BioChaga and BioDihydroquercetin. Meditsinskaya sestra. 2022; 24 (3): 34–40 (in Russ.). doi: 10.29296/25879979-2022-03-07
  35. Maksimova T.M., Kalyagin A.N., Usoltseva O.N., Babanskaya E.B. The possibility of using biodigidrokvertsetin for the prevention of cardiovascular disease in elderly persons engaged in the health groups. Siberian Medical Journal. 2016; 2 (141): 24–9 (in Russ.).
  36. Usoltseva O.N., Olennikov D.N., Potupchik T.V. Evaluation of the quality and biological activity of biodihydroquercetin. Pharmacy. 2022; 71 (8): 5–14 (in Russ.). DOI: 10/29296/25419218-2022-08-01

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies